Articles tagged "Liver transplantation"

2018 American Transplant Congress
Assesment of a Novel Chronic Kidney Disease Educational and Goal Setting Tool among Liver Transplant Recipients
R. Leek,¹ J. Park,¹ C. Koerschner,² J. Mawby,³ J. Wright Nunes,⁴ C. Sonnenday,³ P. Sharma.²
¹College of Pharmacy, University of Michigan, Ann Arbor; ²Gastroenterology and Hepatology, University of Michigan, Ann Arbor; ³Transplantation Surgery, University of Michigan, Ann Arbor; ⁴Nephrology, University of Michigan, Ann Arbor.
Background: Stage 4-5 chronic kidney disease(CKD) among liver transplant(LT) recipients is common and associated with diminished patient and graft outcomes. Our previous study showed that…
2018 American Transplant Congress
Renal and Bone Safety in Post Liver Transplant Patients with Chronic Kidney Disease Receiving Tenofovir Alafenamide for HBV Prophylaxis
E. Gane,¹ B. George,¹ S. Munn,¹ H. Wang,² V. Suri,² A. Gaggar.²
¹Auckland City Hospital, Auckland, New Zealand; ²Gilead Sciences, Foster City, CA.
Background and Aims: Chronic Hepatitis B (CHB) remains a leading indication for orthotopic liver transplantation (OLT) globally. Common complications following OLT include renal dysfunction secondary…
2018 American Transplant Congress
Higher Early Post-Liver Transplant Mortality in Recipients with Severe Alcoholic Hepatitis versus Alcoholic Cirrhosis
B. Lee, G. Im, J. Dodge, M. Voigt, J. Rice, M. Lucey, D. Foley, L. Platt, A. Gurakar, N. Mehta, G. Therapondos, H. Han, D. Victor, O. Fix, L. Dinges, D. Dronamraju, C. Hsu, M. Rinella, H. Maddur, S. Eswaran, J. Hause, R. Ghobrial, Z. Li, N. Terrault.
UCSF, SF; Mt Sinai, NYC; Iowa, Iowa; UW, Madison; Hopkins, Baltimore; Ochsner, Jefferson; USC, LA; Houston Methodist, Houston; Swedish, Seattle; Maryland, Baltimore; UPenn, Philadelphia; NW, Chicago; Rush, Chicago.
INTRODUCTIONThe American Consortium of Early Liver Transplantation for Alcoholic Hepatitis (ACCELERATE-AH) is a multicenter cohort from 8 UNOS regions studying early liver transplant (LT) for…
2018 American Transplant Congress
One-Pump versus Two-Pump Normothermic Ex Vivo Perfusion Machines in Discarded Human Livers
A. Hassan, Q. Liu, D. Pezzati, A. Nassar, B. Soliman, M. Blum, P. Grady, G. Iuppa, T. Uso, J. Fung, K. Abu-Elmagd, C. Quintini.
Transplant Surgery, Cleveland Clinic, Cleveland.
Introduction:Physiologic flows and pressures need to be provided by the ex vivo liver perfusion device. We hypothesized that the 1-pump designed machines would provide the…
2018 American Transplant Congress
Variation in Post-Transplant Opiate Prescribing Patterns across Transplant Centers
A. Mathur, D. Ubl, J. Harbell, K. Croome, C. Taner, J. Heimbach, A. Moss, E. Habermann.
Mayo Clinic, Rochester, Phoenix, Jacksonville.
Background: Excess opiate prescribing has led to an epidemic, and evidence to guide abdominal transplant practice is lacking. We aimed to identify variation in opiate…
2018 American Transplant Congress
Impact of Donor Hepatectomy Time during Organ Procurement in Donation after Circulatory Death Liver Transplantation; The United Kingdom Experience
S. Farid, A. Magdy, D. Vijayanand, V. Upasani, S. Willis, A. Barlow, H. Ernest, A. Niaz.
St James University Hospital, Leeds, United Kingdom.
IntroductionNo data exists to evaluate the impact of hepatectomy time (HT) during donation after cardiac death (DCD) procurement on short and long-term outcomes following liver…
2018 American Transplant Congress
Outcomes after HIV+ Liver Transplant: A HOPE in Action Study
C. Durand,¹ M. Bowring,¹ A. Tobian,^1,3 D. Brown,¹ A. Cameron,¹ S. Ottman,¹ K. Oshima,¹ D. Ostrander,¹ A. Redd,¹ S. Huprikar,² B. Haydel,² S. Lerner,² S. Florman,² S. Chandran,⁶ A. Chao,⁶ V. Kirchner,⁷ T. Pruett,⁷ A. Massie,¹ D. Segev.¹
¹JHU, Baltimore; ²Mount Sinai, New York; ³NIH, Bethesda; ⁴UCSF, San Francisco; ⁵UMN, Minneapolis.
The HOPE in Action Pilot Trial (NCT02602262) is assessing the safety and feasibility of HIV+ deceased donor (D+) kidney and liver transplantation for HIV+ recipients…
2018 American Transplant Congress
Sufficient Hepatic Artery Flow Redeems Poor Portal Vein Flow after Liver Transplantation in Patients with Porta Vein Thrombosis
L. Coromina Hernandez, K. Sasaki, D. Firl, J. McVey, M. Fujiki, F. Aucejo, B. Eghtesad, C. Quintini, C. Miller, K. Hashimoto.
General Surgery, Cleveland Clinic, Cleveland, OH.
Objective:Although portal vein thrombosis(PVT) in liver transplantation is no longer a contraindication, it remains technically challenging. Insufficient intraoperative PV flow after PV thrombectomy/reconstruction was reported…
2018 American Transplant Congress
Incidence Trends among Deceased Liver Transplant Recipients in the United States, 2011-2016: A Propensity Score-Matched Study
R. Schilke, M. Safwan, K. Collins, M. Rizzari, A. Yoshida, M. Abouljoud, S. Nagai.
Transplant Institute, Henry Ford Hospital, Detroit, MI.
BackgroundDonation after cardiac death (DCD) donor liver graft is a known risk factor for graft failure secondary to primary non-function (PNF) and/or diffuse cholangiopathy (DC).…
2018 American Transplant Congress
Real-Time Expert Evaluation of Liver Biopsy for Transplant: The Significance of Smartphone and Microscope Adapter in Telepathology
N. Bath,¹ X. Wang,² J. Bledsoe,² M. Thijssen,¹ A. Ahearn,¹ B. Movahedi,¹ A. Bozorgzadeh,¹ P. Martins.¹
¹Surgery, University of Massachusetts, Worcester, MA; ²Pathology, University of Massachusetts, Worcester, MA.
Introduction: Liver biopsy at the time of procurement plays a crucial role in the acceptance of marginal grafts. Local pathologists and transplant surgery fellows are…